PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page
New Indication for Zerbaxa (ceftolozan & tazobactam) Battles Antimicrobial-resistant Infections

New Indication for Zerbaxa (ceftolozan & tazobactam) Battles Antimicrobial-resistant Infections

by PEPID Newsroom | Jun 4, 2019 | Alerts

The U.S. FDA approved a new indication for Zerbaxa (Ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABD/VABP) in patients 18 years and older. This approval addresses the threat of...

Recent Posts

  • Men’s Health Month – Closing Gaps in Prevention and Early Detection
  • Beyond the Beach – Occupational Skin Cancer Risks in Outdoor Workers
  • Tackling Antimicrobial Resistance: How to fight back against the rise in tough cases
  • The ‘Forever Chemicals’ Crisis: What Healthcare Providers Need to Know About PFAS
  • Top Challenges Faced by Emergency Medicine Residents and How to Overcome Them

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved